v3.20.2
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Operating activities:    
Net income $ 5,293 $ 33,392
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 14,307 14,069
Loss (gain) on disposal of property and equipment 326 (1,926)
Provision for loan losses 44,083 39,483
Benefit for deferred income taxes (2,047) (6,563)
Changes in operating assets and liabilities:    
Notes receivable (5,628) (46,205)
Prepaid expenses and other assets 12,473 (10,586)
Inventory (3,408) (12,672)
Accounts payable, accrued liabilities and other, and deferred income (13,424) 41,333
Net cash provided by operating activities 51,975 50,325
Investing activities:    
Purchases of property and equipment (5,895) (18,502)
Proceeds from sale of property and equipment 167 3,249
Proceeds from repayment of related party loan 80,000  
Net cash provided (used) in investing activities 74,272 (15,253)
Financing activities:    
Proceeds from borrowings collateralized by notes receivable 53,780 79,168
Payments on borrowings collateralized by notes receivable (96,863) (102,631)
Proceeds from borrowings collateralized by line-of-credit facilities and notes payable 80,000 20,386
Payments under line-of-credit facilities and notes payable (65,597) (35,731)
Payments of debt issuance costs (1,134) (255)
Repurchase and retirement of common stock (11,741)  
Dividends paid (95,923) (37,967)
Net cash used in financing activities (137,478) (77,030)
Net decrease in cash and cash equivalents and restricted cash (11,231) (41,958)
Cash, cash equivalents and restricted cash at beginning of period 239,646 273,134
Cash, cash equivalents and restricted cash at end of period 228,415 231,176
Supplemental schedule of operating cash flow information:    
Interest paid, net of amounts capitalized 22,912 26,067
Income taxes paid $ 400 $ 15,200

Source